Pharmaceutical Technology12h
Public health strategies skip patients with rare diseases, says UK study
A study led by UCL found that individuals with rare diseases were five times more likely to die from Covid-19 than the ...
Pharmaceutical Technology19h
Super Bowl ad for copycat weight loss drugs stokes pharma power debate
Controversy surrounded Hims & Hers’ commercial, called ‘Sick of the System’, in the lead up to America’s biggest sporting ...
Pharmaceutical Technology19h
Fourth person receives eGenesis’ gene-edited pig kidney transplant
A 66-year-old man has become the fourth person in the world to receive a genetically edited pig kidney transplant, performed ...
Pharmaceutical Technology23h
FDA approves AbbVie’s Emblaveo for intra-abdominal infections
AbbVie has received US FDA approval for Emblaveo to be used in conjunction with metronidazole for individuals with cIAI.
Pharmaceutical Technology10h
Boehringer seeks approval of lung disease drug after second Phase III success
Nerandomilast is posed to be Boehringer Ingelheim’s successor to its blockbuster Ofev (nintedanib)in IPF and PPF.
Pharmaceutical Technology17h
Keymed’s Stapokibart approved by NMPA for seasonal allergic rhinitis
China's NMPA has granted approval for Keymed Biosciences’ supplemental NDA of Stapokibart to treat seasonal allergic rhinitis ...
Pharmaceutical Technology20h
Eton secures US patent for diabetes insipidus treatment
Eton has secured a patent from the USPTO for its ET-600 product candidate’s desmopressin oral solution formulation for ...
Pharmaceutical Technology3d
Dr Reddy’s and Shanghai Henlius sign agreement for HLX15
Dr Reddy's Laboratories has signed a licence agreement with Shanghai Henlius Biotech to develop and commercialise HLX15, a ...
Pharmaceutical Technology4d
FDA grants orphan drug status to Arbor Biotechnologies’ PH1
The FDA has granted orphan drug designation (ODD) and RPDD to Arbor Biotechnologies' ABO-101, to treat primary hyperoxaluria ...
Pharmaceutical Technology4d
USPTO grants patent to Vistagen’s neuropathic pain treatment
The USPTO has granted a patent to Vistagen’s non-opioid oral product candidate AV-101 for neuropathic pain treatment.
Pharmaceutical Technology7d
Sanofi kicks off share buyback plan with $3bn L’Oréal stake purchase
L'Oréal is selling nearly 30 million shares in Sanofi, decreasing its stake in the drugmaker from 9.4% to 7.2%.
Pharmaceutical Technology4d
Supernus wins FDA approval for Parkinson’s pump on fourth try
The US Food and Drug Administration (FDA) rejected three prior regulatory applications before granting approval.